Canada Reimbursement Profile
By Matthew Brougham, MSc, William O'Neil, PhD, Dima Samaha, MAS, PharmD -
Published 04 October 2017
This profile summarizes reimbursement processes in Canada, presents information for key stakeholders and highlights what should be considered early in the development process.
Categories: Features, Canada, Health Canada, Drugs, Medical Devices, Reimbursement
Tags: CADTH, Health Canada, INESSS, pCPA, PMPRB
Canada Proposes to Amend Drug Pricing Regulations
By Zachary Brennan -
Published 17 May 2017
For the first time in more than two decades, Canada’s government is looking to amend its drug pricing regulations to better protect Canadians from paying excessive prices for patented drugs.
Categories: News, Canada, US, FDA, Health Canada, NICE, Biologics and biotechnology, Drugs, Regulatory intelligence, Regulatory strategy, Research and development
Tags: drug pricing, Canada drug prices, QALY, PMPRB, generic drugmakers